Drug Database
AT

atenolol + nifedipine (nifedipine/atenolol / Bresben / Niften)

✓ Approved

AstraZeneca UK Limited · ADRB1 · 小分子

什么是 atenolol + nifedipine?

atenolol + nifedipine 是一种小分子,由AstraZeneca UK Limited研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名nifedipine/atenolol, Bresben, Niften
公司AstraZeneca UK Limited
药物类别小分子
分子靶点ADRB1, CACNA1C
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

atenolol + nifedipine 作用于 2 个分子靶点:

ADRB1adrenoceptor beta 1 (B1AR, RHR)
CACNA1Ccalcium voltage-gated channel subunit alpha1 C (CaV1.2, CACNL1A1)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

atenolol + nifedipine 针对 2 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Cardiac disordersAngina pectoris✓ Approved
Vascular disordersHypertension✓ Approved

相关研究文献

PubMedRespiratory medicine case reports2026-11-13

Reproducible vasovagal syncope triggered by indwelling pleural catheter drainage: A case of vagal hypersensitivity.

Shah Parita P, Colin Lennon L, Lien Irvin I, Jani Pushan P

Indwelling pleural catheters (IPCs) are generally safe and effective for symptomatic relief and drainage of malignant pleural effusions. Common complications include infection and blockage; however, repeated vasovagal syncopal symptoms during drainage are rare. We report the case of a 62-year-old male with metastatic lung adenocarcinoma complicated by recurrent malignant pleural effusions, who experienced repeated near-syncopal episodes with profound bradycardia (HR < 30 bpm) during the first thoracentesis, during IPC placement and recurrent vasovagal symptoms during subsequent drainage episodes of the catheter at home for two more times. Symptoms were reproducible, occurring even with small-volume removals (<300mL). These episodes were theorized to be due to direct and indirect stimulation of the vagal nerve. The patient was also on atenolol (a betablocker), meaning that his compensatory sympathetic response may have been blunted. Management focused on discontinuation of atenolol and modification of IPC drainage technique (supine positioning and slower flow), which mitigated the episodes. Clinicians must recognize that vagal hypersensitivity, near syncope, and hemodynamic instability are possible complications of IPC drainage.

PMID 43022726
阅读全文 →
PubMedJournal of medical case reports2026-11-13

Multiple co-occurring genetic variants in an elderly patient with Liddle's-like syndrome: a case report and literature review.

Liang Yunlong Y, Zheng YangZhi Y, Yuan Hua H, Guo Li L et al.

Liddle syndrome (LS) is a rare autosomal dominant condition classically defined by early-onset hypertension, hypokalemia, metabolic alkalosis, and a suppressed renin-aldosterone profile, primarily driven by gain-of-function mutations in the SCNN1A, SCNN1B, or SCNN1G genes encoding the epithelial sodium channel (ENaC). Nevertheless, genetically investigated cases exhibiting Liddle's-like phenotypes in the elderly population remain exceptionally rare. We report a 61-year-old male admitted with recurrent limb weakness and resistant hypertension. A comprehensive clinical workup, including biochemical profiles, RAAS evaluation, and 24-h ABPM, was conducted to exclude common secondary causes. Following informed consent, whole-exome sequencing (WES) was performed, with candidate variants validated by Sanger sequencing and assessed per ACMG/AMP guidelines. To guide therapeutic management, a narrative literature review of similar cases was also performed searching PubMed, Web of Science, and CNKI using keywords like "Liddle syndrome," "elderly," "hypertension," and "hypokalemia.". Admission tests showed hypokalemia (2.94 mmol/L), compensated metabolic alkalosis, and suppressed renin-aldosterone levels. 24-h ABPM indicated severe blood pressure fluctuations up to 185/120 mmHg. Genetic testing revealed three heterozygous variants of uncertain significance (VUS)-CYP3A5 (c.1253 + 83C > T), SCNN1G (c.1727A > G, p.Lys576Arg), and WNK1 (c.5636A > T, p.Asp1879Val)-without any known pathogenic variants. A diagnostic trial with triamterene (50 mg twice daily) restored normal potassium levels (> 3.5 mmol/L). After a 30-day combination therapy of controlled-release nifedipine and irbesartan, blood pressure stabilized between 110 and 133 and 69-85 mmHg. We report an elderly patient with chronic hypokalemia and resistant hypertension. After ruling out common secondary causes (for example, primary aldosteronism, Cushing's syndrome, pheochromocytoma), Liddle's-like syndrome was clinically diagnosed based on the low-renin/low-aldosterone biochemical phenotype, compensated metabolic alkalosis, literature review, and a selective response to triamterene. This case suggests that Liddle's-like syndrome must be considered in the differential diagnosis of hypokalemic hypertension in older adults to ensure early and targeted therapy.

PMID 43021310
阅读全文 →
PubMedNew biotechnology2026-11-12

Application of bivalve shells for the removal of trace levels of micropollutants from wastewater under continuous flow conditions.

Jesus Fátima F, Sousa Érika M L ÉML, Pascoal Érica É, Calisto Vânia V et al.

Advanced nature-based systems such as METland® efficiently remove contaminants of emerging concern from municipal wastewater, yet a residual mixture of compounds often persists. This study evaluated bivalve shells as a low-cost polishing step for METland® effluent in two steps: preliminary fixed-bed adsorption experiment comparing the performance of whole clam shells, pyrolyzed clam shells and pyrolyzed oyster shells; a large-scale fixed-bed removal experiment using raw clam shells, calcined clam shells and a shell mixture, integrating LC-MS/MS multiresidue analysis and ecotoxicological assays. Overall, METland® reduced the contaminant load by more than 90%, but the effluent was dominated by persistent compounds and TPs, notably antipyrine derivatives and atenolol acid. In the preliminary experiment, shell-based polishing achieved additional removal (~20-90%) with consistently high reductions for valsartan, paraxanthine, and atenolol acid. In the large-scale experiment, caffeine and paraxanthine showed > 85% removal after 7 days, whereas the atenolol/atenolol acid system showed evidence of pH-induced transformation within the columns, affecting the results. After column treatment, pH increased from approximately 6-7 in the METland® effluent to near-neutral or mildly alkaline values (~7-8), accompanied by an increase in inorganic carbon. Ecotoxicity was largely mitigated by METland®, and shell polishing provided minor additional improvements. This study demonstrates the potential of waste-derived bivalve shells as a sustainable polishing step for METland® effluents under continuous-flow conditions, providing one of the few evaluations of shell-based materials using real wastewater matrices, operational conditions and environmentally relevant contaminant concentrations.

PMID 43020267
阅读全文 →
PubMedJournal of the Endocrine Society2026-11-12

Aortic dilatation and gastrointestinal disease: expansion of the hyperinsulinism-polycystic kidney disease phenotype.

Yau Daphne D, Diaz-Moreno Unai U, Cervi Elena E, Shaunak Meera M et al.

Congenital hyperinsulinism (HI) with polycystic kidney disease (PKD), or HIPKD, is a recently described syndrome caused by a specific promotor variant in PMM2, a gene otherwise associated with PMM2 congenital disorder of glycosylation. To describe the HIPKD clinical phenotype, expanding our understanding and its distinction from the congenital disorder of glycosylation phenotype. Retrospective multicenter cohort study of individuals with HIPKD identified through an international HI genetic referral center. Ten individuals from 9 families compound heterozygous for the promoter variant c.-167G > T and a pathogenic intragenic variant in PMM2. None. Observed clinical features and outcomes. Median age of presentation was 5 months (range 0-42). Median age at follow up was 12.7 years (range 5.4-20.1). HI was managed with diazoxide monotherapy (7/10 patients), diazoxide and nifedipine (2/10 patients), and carbohydrate supplementation alone (1/10 patient). PKD age at diagnosis and severity was variable, ranging from antenatal presentation requiring renal transplantation, to incidental detection in mid-childhood. Liver cysts were noted in 6/10 patients (5/6 with normal liver function). Five of 7 patients had systemic hypertension and 3/5 were normotensive on losartan at last follow up. Inflammatory bowel disease (IBD) with gastric antral foveolar hyperplasia occurred in 4/10 patients, and aortic root and/or ascending aortic dilation in 4/7 patients who underwent echocardiography, 3 of whom also had IBD. HIPKD due to a PMM2 promoter variant is associated with broad, multisystem phenotype, including IBD and aortic dilation. These findings support targeted screening for IBD and cardiovascular surveillance in addition to standard endocrine and renal follow up.

PMID 43016986
阅读全文 →
PubMedInternational journal of pediatric otorhinolaryngology2026-11-11

Management of complex head and neck infantile hemangioma with atenolol - A single-institution 5-year case series.

Jeoung Sarah S, Pauley Jordan J, Klatte Hannah H, El-Feghaly Jinia J et al.

Infantile hemangioma (IH) occurs frequently in the head and neck region. When the IH has no cutaneous involvement or in an area difficult to examine, the pediatric otolaryngologist may be expected to manage. While propranolol is the standard treatment, atenolol is a promising alternative. Some pediatric otolaryngologists are hesitant to prescribe a hemodynamically active medication for an infant. This study describes the experience with atenolol in managing complicated head and neck IHs and hemodynamic changes occurring during medication initiation. This is a case-series of all patients treated with atenolol for IH from 2019 to 2024 at a single tertiary care pediatric otolaryngology practice. Twenty-four patients with head and neck IH were included. 67% were female (n = 16). The most common locations were the nose/nasal cavity (n = 7), cheeks/parotid (n = 6), lip (n = 6), and ear (n = 2). The majority were deep IH (n = 15). Most patients were started on atenolol in the outpatient setting (n = 18) at the mean age of 4.75 months. The average treatment duration was 7.8 months and 75% showed no evidence of rebound growth (n = 19) after medication discontinuation. All cases showed either a partial or complete response to treatment. Though there were statistically significant drops in certain vital signs, no patient required any intervention during medication initiation. Atenolol is well-tolerated and effective for complicated head and neck IHs. It can be safely initiated by the pediatric otolaryngologist in the outpatient clinic.

PMID 43014076
阅读全文 →
PubMedReproductive sciences (Thousand Oaks, Calif.)2026-11-11

The Effect of Nifedipine and NS11021 on the Human Umbilical Artery and Myometrium in Pregnancies Complicated by Intrahepatic Cholestasis.

Uysal Nusret N, Acar-Sahan Selin S, Sengul Mustafa M, Simsek Fatma F et al.

The aim of this study was to investigate the functional responses of umbilical arteries and myometrial smooth muscle tissue from pregnant women with intrahepatic cholestasis and healthy pregnant women to the calcium channel blocker nifedipine and the K⁺ channel opener NS11021, and to evaluate histopathological findings. Umbilical arteries and myometrium were isolated immediately after delivery from 8 healthy and 7 cholestatic pregnant women, and smooth muscle responses to nifedipine (10⁻8-10⁻5 M) and NS11021 (10⁻8-10⁻6 M) were examined in isolated organ baths. Histopathological and immunohistochemical investigations were also performed. In the cholestasis group, the maximum response and sensitivity to nifedipine and NS11021 in the myometrium were not altered, whereas in the umbilical artery, sensitivity to nifedipine decreased, and both maximum response and sensitivity to NS11021 decreased. Histological examinations demonstrated increased apoptosis in the umbilical artery and myometrium. These findings suggest that intrahepatic cholestasis of pregnancy may be associated with more pronounced alterations in pharmacological responses to nifedipine and NS11021 in the umbilical artery than in the myometrium, which may contribute to fetal complications. Further controlled studies are needed to clarify the pathophysiology of intrahepatic cholestasis of pregnancy and related fetal outcomes.

PMID 43013200
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多atenolol + nifedipine